Skip to main content
. Author manuscript; available in PMC: 2006 Jan 25.
Published in final edited form as: Blood. 2004 Dec 21;105(7):2973–2978. doi: 10.1182/blood-2004-09-3660

Figure 3.

Figure 3.

The cumulative incidence of chronic GVHD and relapse as a function of H-Y antibody response. Cumulative incidence of chronic GVHD (cGVHD) and disease relapse were determined as competing risks for H-Y antibody–positive and –negative patients. Those patients who did not experience chronic GVHD or relapse were censored at the time of last follow-up or death.